Ken Griffin Clear Point Neuro, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.3 - $13.18 $38,690 - $96,214	7,300 Added 35.27%	28,000 $313,000
Q2 2024 Aug 14, 2024	SELL	$5.25 - $6.73 $9,975 - $12,787	-1,900 Reduced 8.41%	20,700 $111,000
Q1 2024 May 15, 2024	SELL	$6.03 - $7.86 $157,383 - $205,146	-26,100 Reduced 53.59%	22,600 $153,000
Q4 2023 Feb 14, 2024	SELL	$4.46 - $7.07 $49,060 - $77,770	-11,000 Reduced 18.43%	48,700 $330,000
Q3 2023 Nov 14, 2023	BUY	$5.01 - $7.09 $77,154 - $109,186	15,400 Added 34.76%	59,700 $299,000
Q2 2023 Aug 14, 2023	BUY	$6.54 - $10.58 $124,914 - $202,078	19,100 Added 75.79%	44,300 $320,000
Q1 2023 May 15, 2023	BUY	$7.33 - $10.63 $43,247 - $62,717	5,900 Added 30.57%	25,200 $212,000
Q4 2022 Feb 14, 2023	SELL	$7.7 - $11.21 $300,300 - $437,190	-39,000 Reduced 66.9%	19,300 $163,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $16.49 $110,966 - $186,336	-11,300 Reduced 16.24%	58,300 $604,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.